You have to be registered and logged in for purchasing articles.


Clinicopathological and Prognostic Significance of Serum Cytokine Levels in Breast Cancer by Xin Zhu, Lingbin Du, Jianguo Feng, Yutian Ling, Shenhua Xu

Background: This study was designed to examine the serum levels of six cytokines (IFN-γ, TNF-α, IL-2, IL-4, IL-5, and IL-10) in treated and untreated breast cancer patients and assess their clinical significance. The correlation of the Th1/Th2 type cytokine levels and the clinicopathologic variables was further evaluated.
Methods: Cytometric Bead Array (CBA) was used to examine the levels of Th1 cytokines (TNF-α, IFN-γ, and IL2) and Th2 cytokines (IL-4, IL-5, and IL-10) in serum of 36 untreated and 73 treated breast cancer patients and 51 healthy females as control.
Results: In the untreated group, the levels of IFN-γ, IL-4 and IL-5 were significantly higher than in control group (p < 0.05). IFN-γ, IL-2, IL-5, and IL-10 levels were higher in treated group than in untreated group (p < 0.05); IFN-γ/IL-4 ratio of the treated group was higher than the untreated group (p < 0.05). Meanwhile, the cytokine levels were significantly different in different pTNM stages and lymph node involvement groups. Survival analysis revealed that the IFN-γ/IL-4 ratio, pTNM stage, and lymph node involvement affected the survival of breast cancer patients. The pTNM stage was an independent significant prognostic factor.
Conclusions: Breast cancer patients presented a Th1/Th2 imbalance and immune function disorder, which correlated with pTNM stage and lymph node involvement. Higher IFN-γ/IL-4 ratio predicted a favorable outcome in breast cancer patients.

DOI: 10.7754/Clin.Lab.2013.130738